Publications by authors named "James D Connor"

Claim this Profile
B
Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated children.
Meranda Nakhla, Andrew E Denker, James D Connor, Thomas O Carpenter, Philip D Walson

Clin Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.
Jane C Burns, Brookie M Best, Asuncion Mejias, Lynn Mahony, David E Fixler, James D Connor

J Pediatr· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
Diane T Holland, Robin DiFrancesco, James D Connor, Gene D Morse

Ther Drug Monit· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pregnancy on abacavir pharmacokinetics.
Brookie M Best, Mark Mirochnick, Edmund V Capparelli, Alice Stek, Sandra K Burchett, James D Connor

AIDS· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Roger L Shapiro, Diane T Holland, Edmund Capparelli, Shahin Lockman, Ibou Thior, James D Connor

J Infect Dis· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental pharmacokinetics and pharmacodynamics of nizatidine.
Susan M Abdel-Rahman, Franklin K Johnson, James D Connor, Annamaria Staiano, Christophe Dupont

J Pediatr Gastroenterol Nutr· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.
Diane T Holland, Robin DiFrancesco, Judith Stone, Fayez Hamzeh, James D Connor

Antimicrob Agents Chemother· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease.
Brookie M Best, Jane C Burns, John DeVincenzo, Stephanie J Phelps, Jeffrey L Blumer, James D Connor

Curr Ther Res Clin Exp· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.
Edmund V Capparelli, Janet A Englund, James D Connor, Stephen A Spector, Ross E McKinney

J Clin Pharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and tolerance of zidovudine in preterm infants.
Edmund V Capparelli, Mark Mirochnick, Wayne M Dankner, Suzette Blanchard, Lynne Mofenson, James D Connor

J Pediatr· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis